DuPont and Hohenstein to Launch New Testing Protocols for Body Armor Comfort and Mobility Assessment
Werte in diesem Artikel
WILMINGTON, Del., Nov. 3, 2025 /PRNewswire/ -- DuPont (NYSE: DD) today announced the launch of three innovative testing protocols that set a new benchmark for evaluating the comfort and mobility of soft ballistic body armor. Developed in collaboration with independent textile research and testing institute Hohenstein, the testing methods are designed to simulate real-world movements and situations to identify discomfort levels and mobility constraints faced by law enforcement and military personnel.
Police officers often reference lack of comfort as a key reason for removing their body armor on duty. Additionally, restricted mobility leads to body fatigue, which weakens focus, slows reactions and increases the risk of injury.
"Maximizing comfort and flexibility in soft ballistic solutions is essential to address the critical needs of law enforcement and military personnel," said Christophe Djololian, Global Market Development Leader at DuPont. "By taking into account body movement and specific end-use scenarios, we have developed solutions that more objectively evaluate discomfort and mobility constraints from the wearer's perspective."
Three Comfort & Mobility Tests have been developed:
- Lower Costal Bending (LCB) Test simulates upper body bending motions common in active duty, and measures energy loss due to armor stiffness, which can lead to accelerated fatigue in the field.
- Double Curvature Compression (DCC) Test replicates a bent torso to assess how well ballistic materials conform to the body's complex curves. High conformability = enhanced freedom of movement.
- Edge Pressure (EP) Test evaluates localized pressure points at the vest edges, such as the lower abdomen, neck and arms, which are often causes of discomfort.
These test methods were developed in collaboration with Hohenstein, a German-based research institute with strong expertise in textile testing and ergonomics.
"It is in the DNA of Hohenstein to get as close as possible to the user's reality," said Dr. Jan Beringer, Senior Scientific Expert at Hohenstein. "With dedicated wear trials, possible discomfort and movement restrictions were determined. Then, leveraging decades of expertise, tests and equipment were designed to simulate the wearer's experience in close collaboration between DuPont and Hohenstein."
"It is our intent to drive the industry to more comfortable body armor to improve the performance and protection of military and law enforcement personnel. With these new comfort and mobility test protocols developed with Hohenstein, we can now quantify and standardize flexibility in body armor so protection and comfort go hand in hand. As we design new, more flexible materials such as Kevlar® EXO™ fabrics and structures, a wide range of highly optimized solutions for the greater benefit of end-users is now possible," said DuPont Global Segment Leader, Steven LaGanke.
How to access the new testing protocols?
The three test methods to characterize comfort & mobility constraints for soft ballistic applications are available on the Hohenstein website here.
You can also learn more about the different testing methods here.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets, including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
About Hohenstein
Hohenstein is a family-owned company with more than 75 years of experience in testing, certification and research. Customers around the world benefit from a one-stop service: around 1,500 employees support businesses along the entire value chain, from testing and certification to marketing their products. Hohenstein's testing portfolio includes softlines – textile materials –, hardlines – consumer goods made from rigid materials –, as well as medical devices. As an accredited testing laboratory, Hohenstein Medical provides independent evidence of the effectiveness and safety of medical devices through biological, chemical and physical laboratory tests. The Hohenstein experts also support their customers with interdisciplinary knowledge for customised testing solutions beyond standard methods.
www.hohenstein.com
Media Contact:
Olivia Stover
dupont@nextpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-and-hohenstein-to-launch-new-testing-protocols-for-body-armor-comfort-and-mobility-assessment-302600514.html
SOURCE DuPont Kevlar® EXO™
Übrigens: DuPont de Nemours und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf DuPont de Nemours
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DuPont de Nemours
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu DuPont de Nemours
Analysen zu DuPont de Nemours
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.10.2021 | DuPont de Nemours Overweight | JP Morgan Chase & Co. | |
| 20.08.2019 | DowDuPont Outperform | Cowen and Company, LLC | |
| 25.06.2019 | DowDuPont Neutral | Monness, Crespi, Hardt & Co. | |
| 10.06.2019 | DowDuPont Outperform | Cowen and Company, LLC | |
| 06.02.2019 | DowDuPont Market Perform | Cowen and Company, LLC |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.10.2021 | DuPont de Nemours Overweight | JP Morgan Chase & Co. | |
| 20.08.2019 | DowDuPont Outperform | Cowen and Company, LLC | |
| 10.06.2019 | DowDuPont Outperform | Cowen and Company, LLC | |
| 12.10.2018 | DowDuPont buy | Deutsche Bank AG | |
| 29.03.2018 | DowDuPont Outperform | BMO Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.06.2019 | DowDuPont Neutral | Monness, Crespi, Hardt & Co. | |
| 06.02.2019 | DowDuPont Market Perform | Cowen and Company, LLC | |
| 12.09.2017 | DowDuPont Neutral | Monness, Crespi, Hardt & Co. | |
| 31.05.2017 | Dow Chemical Market Perform | Cowen and Company, LLC | |
| 26.04.2017 | DuPont (E I DuPont de Nemours and Sector Perform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.01.2009 | Dow Chemical verkaufen | Euro am Sonntag | |
| 11.04.2007 | Dow Chemical verkaufen | Hamburger Sparkasse | |
| 03.02.2006 | Update Rohm and Haas Co.: Reduce | UBS | |
| 07.07.2005 | Update Rohm and Haas Co.: Sell | Longbow |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DuPont de Nemours nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
